Latest news with #CaloPix®
Miami Herald
21-05-2025
- Business
- Miami Herald
CORRECTING and REPLACING: Tribun Health Achieves FDA Clearance for CaloPix Digital Pathology Platform With Dual Scanner Compatibility
[CORRECTED RELEASE] Updated to clarify reference to dual-scanner FDA clearance. PARIS, FRANCE / ACCESS Newswire / May 21, 2025 / Tribun Health, a leader in digital pathology, proudly announces that its flagship web-based image management system, CaloPix®, has received FDA 510(k) clearance for use with two leading whole slide imaging scanners: the Hamamatsu NanoZoomer S360MD and the Leica Aperio GT450 DX. This double clearance is representing a major step forward for the U.S. adoption of vendor-agnostic, enterprise-grade solutions. This clearance builds on CaloPix's strong regulatory track record: the solution is CE-marked, Health Canada-approved, and trusted by more than 100 hospitals and laboratories across Europe and Canada. With over 1,000 active users of CaloPix® worldwide, this milestone underscores the platform's scalability, performance, and rapid adoption across diverse healthcare systems. Now, with FDA clearance secured, Tribun Health is ready to bring its proven enterprise solution to hospitals and labs across the United States. Besides these regulatory achievements, CaloPix® has also been recognized three times as "Best in KLAS" for digital pathology, a global benchmark for excellence in healthcare IT. This prestigious recognition highlights Tribun Health's commitment to customer satisfaction, operational excellence, and product innovation. "This is a major commercial and clinical milestone for us," said Jean-François Pomerol, CEO of Tribun Health. "We're entering the U.S. with a solution that has already proven its value in demanding, high-throughput clinical environments. With CaloPix®, we offer a platform trusted by top-tier institutions, awarded Best in KLAS multiple times -and now validated by the FDA. As the market accelerates toward widespread clinical adoption, we're thrilled to expand our reach and solidify our position as a truly global player." Built for Enterprise, Designed for Performance, Ready for Cloud CaloPix® goes far beyond a traditional image viewer-it's a powerful, all-in-one digital pathology platform tailored for the needs of modern healthcare systems, large hospital networks, and academic institutions. Key capabilities include: Web-based, cloud-ready, zero-footprint architecture-no local installation required High-throughput case management and diagnostic reporting to streamline daily workflowsSeamless integration with LIS and VNA systems for unified data access across the enterpriseBuilt-in telepathology and remote collaboration tools for second opinions and network-wide consultationsArchiving, export, and quality control features to support regulatory compliance and research initiatives Meeting the Moment: Solving U.S. Market Challenges The U.S. faces a growing mismatch between rising pathology case volumes and a shrinking workforce. At the same time, there is a clear push for multi-site collaboration, integrated diagnostics, and precision medicine initiatives. With this FDA clearance, CaloPix® empowers U.S. hospitals and labs to: Digitize pathology workflows at scaleReduce turnaround times and improve reporting accuracyCollaborate remotely across institutionsPrepare for AI adoption with structured, interoperable data Building on our success with public health networks, cancer centers, academic hospitals and private laboratory groups across Europe and Canada, we are now ready to scale in the world's largest healthcare market-the United States. * CaloPix® is CE-marked, Health Canada-approved, and FDA 510(k) cleared. Please refer to the Instructions for Use (IFU) for intended purpose and regulatory indications. About Tribun Health Tribun Health is a global leader in digital pathology, offering award-winning solutions that improve workflow efficiency, diagnostic accuracy, and patient outcomes. We assist hospitals and laboratories in transitioning from glass slide pathology to fully digital solutions, leveraging AI and data-driven technology to enhance precision and reduce turnaround times. Our mission is simple: to ensure every cancer patient receives a timely and informed diagnosis-because every moment counts. By advancing pathology with cutting-edge innovations, we are shaping the future of cancer care. For more information, visit Tribun Health and follow us on LinkedIn and X. SOURCE: Tribun Health press release
Miami Herald
20-05-2025
- Business
- Miami Herald
Tribun Health Achieves FDA Clearance for CaloPix Digital Pathology Platform With Dual Scanner Compatibility
Paving the way for U.S. Market Entry and Global Expansion PARIS, FRANCE / ACCESS Newswire / May 20, 2025 / Tribun Health, a leader in digital pathology, proudly announces that its flagship web-based image management system, CaloPix®, has received FDA 510(k) clearance for use with two leading whole slide imaging scanners: the Hamamatsu NanoZoomer S360 and the Leica Aperio GT450. This marks the first time a digital pathology software has been cleared with both scanners, representing a major step forward for the U.S. adoption of vendor-agnostic, enterprise-grade solutions. This clearance builds on CaloPix's strong regulatory track record: the solution is CE-marked, Health Canada-approved, and trusted by more than 100 hospitals and laboratories across Europe and Canada. With over 1,000 active users of CaloPix® worldwide, this milestone underscores the platform's scalability, clinical reliability, and rapid adoption across diverse healthcare systems. Now, with FDA clearance secured, Tribun Health is ready to bring its proven enterprise solution to hospitals and labs across the United States. Besides these regulatory achievements, CaloPix® has also been recognized three times as "Best in KLAS" for digital pathology, a global benchmark for excellence in healthcare IT. This prestigious recognition highlights Tribun Health's commitment to customer satisfaction, operational excellence, and product innovation. "This is a major commercial and clinical milestone for us," said Jean-François Pomerol, CEO of Tribun Health. "We're entering the U.S. with a solution that has already proven its value in demanding, high-throughput clinical environments. With CaloPix®, we offer a platform trusted by top-tier institutions, awarded Best in KLAS multiple times -and now validated by the FDA. As the market accelerates toward widespread clinical adoption, we're thrilled to expand our reach and solidify our position as a truly global player." Built for Enterprise, Designed for Performance, Ready for Cloud CaloPix® goes far beyond a traditional image viewer-it's a powerful, all-in-one digital pathology platform tailored for the needs of modern healthcare systems, large hospital networks, and academic institutions. Key capabilities include: Web-based, Cloud ready, zero-footprint architecture-no local installation requiredHigh-throughput case management and diagnostic reporting to streamline daily workflowsSeamless integration with LIS and VNA systems for unified data access across the enterpriseBuilt-in telepathology and remote collaboration tools for second opinions and network-wide consultationsArchiving, export, and quality control features to support regulatory compliance and research initiatives Meeting the Moment: Solving U.S. Market Challenges The U.S. faces a growing mismatch between rising pathology case volumes and a shrinking workforce. At the same time, there is a clear push for multi-site collaboration, integrated diagnostics, and precision medicine initiatives. With this FDA clearance, CaloPix® empowers U.S. hospitals and labs to: Digitize pathology workflows at scaleReduce turnaround times and improve reporting accuracyCollaborate remotely across institutionsPrepare for AI adoption with structured, interoperable data Building on our success with public health networks, cancer centers, academic hospitals and private laboratory groups across Europe and Canada, we are now ready to scale in the world's largest healthcare market-the United States. * CaloPix® is CE mark, HC cleared, FDA cleared. Please refer to IFU for intended use. About Tribun Health Tribun Health is a global leader in digital pathology, offering award-winning solutions that improve workflow efficiency, diagnostic accuracy, and patient outcomes. We assist hospitals and laboratories in transitioning from glass slide pathology to fully digital solutions, leveraging AI and data-driven technology to enhance precision and reduce turnaround times. Our mission is simple: to ensure every cancer patient receives a timely and informed diagnosis-because every moment counts. By advancing pathology with cutting-edge innovations, we are shaping the future of cancer care. For more information, visit Tribun Health and follow us on LinkedIn and X. Contact Information Andreia Beyer VP, Global Marketing & Managing Director, North Americaabeyer@ (416) 565-0474 SOURCE: Tribun Health press release
Miami Herald
06-05-2025
- Health
- Miami Herald
Tribun Health Achieves ISO/IEC 27001 Certification, Strengthening Commitment to Data Security in Digital Pathology
Press Releases Tribun Health Achieves ISO/IEC 27001 Certification, Strengthening Commitment to Data Security in Digital Pathology Tribun Health, a leader in digital pathology software and AI-powered diagnostic solutions, is proud to announce that it has been awarded the ISO/IEC 27001 certification-an internationally recognized standard for information security management systems (ISMS). This achievement underscores Tribun Health's ongoing commitment to the highest standards of data protection, patient confidentiality, and operational excellence. In a field where security and privacy are non-negotiable, ISO 27001 certification validates that the company has implemented a robust framework to identify, manage, and reduce risks to sensitive information. "Our clients trust us with more than just images-they trust us with lives," said Zina Hamoumi, Chief Operating Officer at Tribun Health. "Achieving ISO 27001 reflects the discipline, structure, and dedication our teams bring to protecting that trust every single day." "This certification is not just a badge-it's a reflection of our core values," added Jean-François Pomerol, CEO of Tribun Health. "As we continue expanding globally, we remain deeply committed to earning and maintaining the confidence of our partners, customers, and the patients they serve." Used by pathology labs, hospitals, and healthcare networks worldwide, Tribun Health's CaloPix® platform manages millions of digital slides annually. As data volumes grow and collaboration across institutions increases, the need for stringent, transparent security measures becomes even more critical. ISO 27001 certification confirms that Tribun Health meets those standards, offering peace of mind to healthcare professionals and IT departments alike. Tribun Health continues to expand its footprint across Europe, North America and other regions, providing digital pathology platforms that are not only innovative but also safe and dependable. This certification builds on Tribun Health's long-standing commitment to data security, offering formal recognition of the rigorous controls already in place. About Tribun Health Tribun Health is a global leader in digital pathology, offering award-winning solutions that improve workflow efficiency, diagnostic accuracy, and patient outcomes. We assist hospitals and laboratories in transitioning from glass slide pathology to fully digital solutions, leveraging AI and data-driven technology to enhance precision and reduce turnaround times. Our mission is simple: to ensure every cancer patient receives a timely and informed diagnosis-because every moment counts. By advancing pathology with cutting-edge innovations, we are shaping the future of cancer care. For more information, visit Tribun Health and follow us on LinkedIn and X. Contact Information Andreia Beyer VP, Global Marketing & Managing Director, North America abeyer@ +1 (416) 565-0474 SOURCE: Tribun Health press release This story was originally published May 6, 2025 at 8:06 AM.
Miami Herald
20-03-2025
- Business
- Miami Herald
CGI and Tribun Health Expand Digital Pathology Leadership in Denmark with New Regional Win
PARIS, FR / ACCESS Newswire / March 20, 2025 / CGI and Tribun Health have won their second multi-site regional project in Denmark, expanding their successful partnership in digital pathology. Following their initial victory in Region Sjælland, the duo has now secured a major contract in Region Nordjylland, further strengthening their position in Denmark's healthcare digitalization efforts. As the prime integrator, CGI is leading the project while Tribun Health provides its CaloPix® solution - a fully DICOM-compliant image management system designed to enhance pathology workflows, interoperability, and multi-site collaboration. "Winning a second regional project in Denmark reaffirms the strength of our partnership with CGI and the trust placed in our solutions," said Jean-François Pomerol, CEO of Tribun Health. "With CaloPix, we are enabling seamless integration within hospital ecosystems, boosting efficiency, and enhancing diagnostic precision across multiple sites." CGI and Tribun Health Strengthen Their Presence in Danish Healthcare The new deployment in Region Nordjylland underscores the growing demand for scalable, interoperable digital pathology solutions. By implementing CaloPix® IMS, healthcare pathologists across the region will benefit from standardized imaging, enhanced remote collaboration, and optimized workflows. Henrik Mejlgaard, Vice President of CGI's Health Solutions in Denmark, emphasized the importance of this collaboration. "Our continued success in Denmark with Tribun Health highlights the critical role of digital transformation in pathology. Region Nordjylland's investment in advanced imaging and interoperability through CaloPix IMS will enable more efficient diagnostics and better patient outcomes. We look forward to supporting the region in its transition to a fully digital pathology workflow." Driving Innovation in Scandinavian Healthcare With two major regional wins in Denmark, CGI and Tribun Health are well-positioned to drive further innovation and efficiency in pathology across Denmark and beyond. This expansion reinforces their commitment to providing state-of-the-art digital pathology solutions that empower pathologists and healthcare institutions with precision, scalability, and AI-driven insights. About Tribun Health Tribun Health is a global leader in digital pathology, delivering award-winning solutions that enhance workflow efficiency, and diagnostic precision. We empower hospitals and laboratories transitioning from glass slide pathology to fully digital solutions, leveraging AI and data-driven technology to improve accuracy and reduce turnaround times. Our mission is simple: to ensure every cancer patient receives a timely, informed diagnosis - because every moment matters. By advancing pathology with cutting-edge innovation, we are shaping the future of cancer care. Follow us on LinkedIn and X. About CGI Founded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 91,500 consultants and professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. CGI Fiscal 2023 reported revenue is $14.30 billion and CGI shares are listed on the TSX (GIB.A) and the NYSE (GIB). Learn more at SOURCE: Tribun Health press release
